Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Public Health Weekly Report|June 24, 2026
Nationwide Measles Seroprevalence in the Republic of Korea, 2023Ah-Ra Kim, Seung-Jung Kee, Hyun-Woo Choi, et al.Laboratory Animal Research|July 13, 2012
Historical control data from 13-week repeated toxicity studies in Crj:CD (SD) ratsJung-Min Lee, Min-Ah Lee, Hyeon-Nam Do, et al.Epidemiology and Health|February 25, 2022
Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination SurveyAh-Ra Kim, Dohsik Minn, Su Hwan Kim, et al.Journal of Korean Medical Science|March 11, 2025
Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell CountNa Young Ha, Ah-Ra Kim, Hyeongseok Jeong, et al.Infection & Chemotherapy|April 6, 2023
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in KoreaHeeji Lim, Sundong Jang, Hyun Ju In, et al.Vaccines|October 28, 2023
Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis PatientsYoosun Joo, Dae Kyu Kim, Yun Gi Jeon, et al.Epidemiology and Health|October 13, 2022
Seroprevalence of SARS-CoV-2 antibodies during the third wave of COVID-19 in the Seoul metropolitan area of KoreaKyuhyun Yoon, Jayeun Kim, Kyong Ran Peck, et al.Open Forum Infectious Diseases|June 1, 2026
Protective Effectiveness of Sars-Cov-2 Infection Risk Among Hybrid, Vaccine, and Infection-induced Immunity Against the Omicron Variant, K-SerosmartYifan Zhang, Won Chang, Kevin Dieckhaus, et al.Annals of Laboratory Medicine|August 10, 2021
Performance Comparison of Five SARS-CoV-2 Antibody Assays for Seroprevalence StudiesYounhee Park, Ki Ho Hong, Su-Kyung Lee, et al.Pageof 1